Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ALK |
| Variant | S1206Y |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | ALK S1206Y lies within the protein kinase domain of the Alk protein (UniProt.org). S1206Y has been demonstrated to occur as a secondary drug resistance mutation in the context of ALK rearrangements (PMID: 22277784, PMID: 24675041, PMID: 25727400), but has not been biochemically characterized and therefore, its effect on Alk protein function is unknown (PubMed, Dec 2025). |
| Associated Drug Resistance | Y |
| Category Variants Paths |
ALK mutant ALK S1206Y |
| Transcript | NM_004304.5 |
| gDNA | chr2:g.29220734G>T |
| cDNA | c.3617C>A |
| Protein | p.S1206Y |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_004304.4 | chr2:g.29220734G>T | c.3617C>A | p.S1206Y | RefSeq | GRCh38/hg38 |
| NM_004304 | chr2:g.29220734G>T | c.3617C>A | p.S1206Y | RefSeq | GRCh38/hg38 |
| NM_004304.5 | chr2:g.29220734G>T | c.3617C>A | p.S1206Y | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| ALK S1206Y | Advanced Solid Tumor | predicted - sensitive | APG-2449 | Preclinical - Biochemical | Actionable | In a preclinical study, APG-2449 inhibited the kinase activity of ALK S1206Y in culture (PMID: 35820889). | 35820889 |